Apteki 36.6 Financial Statements (APTK)
|
|
|
|
Report date
|
|
|
30.04.2020 |
30.04.2021 |
08.08.2023 |
17.07.2023 |
02.05.2024 |
|
Currency
|
|
|
RUB |
RUB |
RUB |
RUB |
RUB |
|
Financial report URL
|
|
|
|
|
|
|
|
|
Annual report URL
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
46.1 |
39.3 |
44.1 |
59.1 |
67.4 |
|
EBITDA, bln rub |
? |
|
-3.59 |
4.70 |
|
|
|
|
Net profit, bln rub |
? |
|
-8.86 |
6.40 |
-0.950 |
0.223 |
0.120 |
|
|
OCF, bln rub |
? |
|
|
|
3.23 |
6.60 |
7.05 |
|
CAPEX, bln rub |
? |
|
1.82 |
1.70 |
0.980 |
0.980 |
0.650 |
|
FCF, bln rub |
? |
|
|
|
-1.71 |
1.64 |
2.68 |
|
|
Ordinary share dividend yield, %
|
|
|
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
|
Dividend payout ratio, %
|
|
|
0% |
0% |
0% |
0% |
0% |
|
|
Cost of production, bln rub |
|
|
32.9 |
25.7 |
29.0 |
38.9 |
45.1 |
|
Amortization, bln rub |
|
|
|
|
5.8 |
5.8 |
6.0 |
|
Employment expenses, bln rub |
|
|
6.31 |
6.27 |
6.78 |
7.92 |
8.91 |
|
Interest expenses, bln rub |
|
|
4.30 |
4.05 |
4.92 |
4.27 |
4.06 |
|
|
Assets, bln rub |
|
|
32.6 |
54.4 |
37.8 |
43.6 |
53.2 |
|
Net Assets, bln rub |
? |
|
-23.6 |
-5.70 |
-6.65 |
-6.41 |
-6.83 |
|
Debt, bln rub |
|
|
33.2 |
40.2 |
21.6 |
18.9 |
20.7 |
|
Cash, bln rub |
|
|
0.850 |
1.000 |
1.73 |
0.810 |
2.09 |
|
Net debt, bln rub |
|
|
32.3 |
39.2 |
19.9 |
18.1 |
18.6 |
|
|
Ordinary share price, rub |
|
|
12.3 |
14.0 |
14.0 |
11.6 |
14.2 |
|
Number of ordinary shares, mln |
|
|
2 331 |
2 331 |
2 331 |
2 331 |
2 331 |
|
|
Market cap, bln rub |
|
|
28.6 |
32.5 |
32.5 |
27.0 |
33.1 |
|
EV, bln rub |
? |
|
60.9 |
71.7 |
52.4 |
45.1 |
51.7 |
|
Book value, bln rub |
|
|
-33.2 |
-18.2 |
-19.5 |
-19.9 |
-24.0 |
|
|
EPS, rub |
? |
|
-3.80 |
2.75 |
-0.41 |
0.10 |
0.05 |
|
FCF/share, rub |
|
|
0.00 |
0.00 |
-0.73 |
0.70 |
1.15 |
|
BV/share, rub |
|
|
-14.2 |
-7.81 |
-8.37 |
-8.54 |
-10.3 |
|
|
EBITDA margin, % |
? |
|
-7.8% |
12.0% |
0.0% |
0.0% |
0.0% |
|
Net margin, % |
? |
|
-19.2% |
16.3% |
-2.2% |
0.4% |
0.2% |
|
FCF yield, % |
? |
|
0.0% |
0.0% |
-5.3% |
6.1% |
8.1% |
|
ROE, % |
? |
|
37.6% |
-112.3% |
14.3% |
-3.5% |
-1.8% |
|
ROA, % |
? |
|
-27.2% |
11.8% |
-2.5% |
0.5% |
0.2% |
|
|
P/E |
? |
|
-3.23 |
5.08 |
-34.2 |
120.9 |
276.2 |
|
P/FCF |
|
|
|
|
-19.0 |
16.4 |
12.4 |
|
P/S |
? |
|
0.62 |
0.83 |
0.74 |
0.46 |
0.49 |
|
P/BV |
? |
|
-0.86 |
-1.79 |
-1.67 |
-1.35 |
-1.38 |
|
EV/EBITDA |
? |
|
-17.0 |
15.2 |
|
|
|
|
Debt/EBITDA |
|
|
-9.00 |
8.33 |
|
|
|
|
|
Employees, people |
|
|
|
5 904 |
|
|
|
|
Labour productivity, mln rub/person/year |
|
|
|
6.66 |
|
|
|
|
Expenses per employee, thousand rub |
|
|
|
1 062 |
|
|
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
|
CAPEX/Revenue, % |
|
|
4% |
4% |
2% |
2% |
1% |
|
| Apteki 36.6 shareholders |
